Navigation Links
Journal of Alzheimer's Disease special issue explores multifaceted aspects of AD
Date:11/15/2007

Amsterdam, November 15, 2007 A recently published special issue of the Journal of Alzheimer's Disease contains the contributions from experts in the field of aging, dementia and Alzheimers disease, who attended the Fourth Annual Meeting on Brain aging and Dementia: From successful aging to severe dementia. Held in Perugia in October 2006 under the auspices of the Italian Psychogeriatric Association, a member of the International Psychogeriatric Association, the meeting celebrates the centenary of Alzheimers first description of the disease.

The articles cover several topics on AD: sociological, epidemiological, clinical and biological aspects offer a wide overview on this multifaceted disease.

Robert Binstock, from Case Western Reserve University, Cleveland (USA), reports some reflections on the ethical, moral and policy challenges for healthcare professionals and politicians due to the aging of industrialized nations. This social phenomenon is associated with an enhanced demand for both acute and long-term healthcare for the elderly that will increasingly strain economic resources.

Laura Fratiglioni and Hui-Xin Wang, from the Karolinska Institute of Stockholm (Sweden), review the concept of brain reserve that refers to the ability to tolerate the age-related changes and disease-related pathology in the brain without developing clear clinical symptoms. Epidemiological studies indicate that brain reserve is related to a number of aspects including high education, adult-life occupational work complexity, as well as a mentally and socially integrated lifestyle.

Guest Editor Patrizia Mecocci and colleagues from the Italian University of Perugia (Elena Mariani) and University of Palermo (Roberto Monastero) review the most recent aspects related to the epidemiological, clinical, neuropathological, neuroimaging, biochemical and therapeutic aspects of Mild Cognitive Impairment, a nosological entity proposed as an intermediate state
'/>"/>

Contact: Astrid Engelen
a.engelen@iospress.nl
31-206-883-355
IOS Press
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. News briefs from the journal Chest, August 2007
2. The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia
3. Elsevier launches new journal: Stem Cell Research
4. Elsevier announces new journal on inflammatory bowel diseases
5. National Osteoporosis Foundation Teams Up With Ladies Home Journal Magazine to Launch a 10-city Mall Walk Tour
6. Cleveland Clinic Press Releases Journal-Writing Book Write for Life: Healing Body, Mind, and Spirit Through Journal Writing by Sheppard B. Kominars, Ph.D.
7. Good Clinical Practice Journal Awards: Winners Announced
8. Maimonides Expands Circulation of Physicians Practice Journal to Staten Island Doctors
9. American Heart Association Surgical Supplement Journal Report: Appropriate Hospital Discharge System Can Prevent Future Cardiac Events
10. Takeda statement on ACTOS meta-analysis published in the Journal of the American Medical Association
11. Takeda Statement on ACTOS(R) (Pioglitazone HCl) Meta-Analysis Published in the Journal of the American Medical Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...ov. 21 The Generic,Pha...ing statement today from,GPhA President and CEO K...ion,(FTC) roundtable on "Emerging Health Care Com...fact that the FTC is conducting this roundtable de...hat consumers have access to safe and,affordable ...
(Date:11/21/2008)... day lead to a novel technique to combat cancer, s...hDay News) -- Belgian researchers have discovered ...sugar for food, and this might lead to new treatme...ive and proliferate, all cells in the body need to...ucose], a process that requires oxygen. Compared w...
(Date:11/21/2008).... 21 NursingCenter.com, the premie...d peer reviewed content, has been,updated to impr...istered,users. Powered by Lippincott Williams &am...over 900 peer-reviewed continuing education activi... than 50 leading nursing journals.,Lippincott Wil...
(Date:11/21/2008)... The general membership of the Med...ee new individuals at their Annual,Awards Dinner ...n New York. A,Lifetime Achievement Award will als...edical Advertising Hall of Fame are: , Ronald P...account position,at Sudler & Hennessey. In 19...
Breaking Medicine News(10 mins):Health News:GPhA Statement on FTC Roundtable on Biogenerics 2Health News:New Approach Keeps Tumor Cells From Refueling 2Health News:NursingCenter.com Launches New Features to Improve User Experience 2Health News:NursingCenter.com Launches New Features to Improve User Experience 3Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 2Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 3
...ttle in Afghanistan are increasingly suffering fro... disorders, say// concerned experts. Ontario’s o...tigation into the matter. It was seen that a cente...dren was caught in a mire of poor funding due to g...
... who had been protesting the alleged manhandling o...third day Friday after Delhi// Health Minister Yog...ecurity would be looked into. "We called off the ... us a written assurance to provide better security...
...lux testing appear in The American Journal of Gast...an College of// Gastroenterology, these guidelines...ease (GERD) diagnostic testing and how they have m...phageal disorders. “Gastroenterologists are confr...
...usting drug remains the most beneficial proven int...an Heart Association.// The Guidelines for the E...o indicate that new options – such as intra-arteri...d mechanical removal of blood clots – show promise...
Other Medicine News:Health News:Collateral Damage-Children Of Canadian Soldiers Suffer 2Health News:Intravenous Delivery of Clot-busting Drug Still Best Intervention for Ischemic Stroke 2
(Date:11/20/2008)... BOSTON, Nov. 20 PAREXE...eading global biopharmaceutical services provider,...ima, Peru to provide regulatory consulting and cli...the Peru office, PAREXEL now has locations through...tin America, which also include Argentina, Brazil,...
(Date:11/19/2008)... , , Study did not achieve statistical si...wswire-FirstCall/ -- Pharmos Corporation (Nasdaq: ... clinical trial of its topical NanoEmulsion (NE) d...nac Diethanolamine. , , The multi-center, r...y evaluated the safety and efficacy of the Company...
(Date:11/19/2008)... -Triggers $5 Million Payment from Roche- , ,... -- Memory Pharmaceuticals Corp. (Nasdaq: MEMY )...nt goal for its Phase 2 trial of R3487/MEM 3454, i...nitive impairment associated with schizophrenia (C...the Phase 2 trial, triggering a $5.0 million payme...
(Date:11/18/2008)... LANSDOWNE, Va., Nov. 18 /PRNewswire-USNewswire/ ...sts gathered at a November national forum to consi...ca,s public health and national economy from outbr...er announced today. , , Among those innovat...on every American kitchen table that detects highl...
Breaking Medicine Technology:PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 342 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases 2Vendormate Again Selected as Top 40 Georgia Innovative Technology Company 13787 1Vendormate Again Selected as Top 40 Georgia Innovative Technology Company 13787 2New TB test means quicker and easier diagnosis for patients 13783 1New TB test means quicker and easier diagnosis for patients 13783 2New TB test means quicker and easier diagnosis for patients 13783 3Curing addiction with cannabis medicines 13779 1Curing addiction with cannabis medicines 13779 2Wandering albatrosses follow their nose 2438 1Wandering albatrosses follow their nose 2438 2
... March 26, 2007 /PRNewswire/ -- CSL Limited today,...urnal of the,American Medical Association that sug...utely raise HDL ("good" cholesterol) levels,may r...s of,patients with a recent episode of acute coron...ribe unstable angina and myocardial,infarction (he...
...(BUSINESS WIRE)--Mar 26, 2007 - Two-year results f...nfirm the positive,clinical profile of the Endeavo...ly 1,300 the number of Endeavor patients who have ...ong those 1,300,Endeavor patients, there have been...the independent, pre-specified clinical trial,prot...
Other Medicine Technology:CSL Therapy That Mimics 'Good' Cholesterol May Reduce Plaque Volume,in Coronary Arteries 2CSL Therapy That Mimics 'Good' Cholesterol May Reduce Plaque Volume,in Coronary Arteries 3CSL Therapy That Mimics 'Good' Cholesterol May Reduce Plaque Volume,in Coronary Arteries 4Two-Year Results from the Medtronic ENDEAVOR III Trial Confirm,Stent's Positive Clinical Profile 2Two-Year Results from the Medtronic ENDEAVOR III Trial Confirm,Stent's Positive Clinical Profile 3
...arefully considered with both the practitioner and...ptimum viewing angle and the largest field of view...r perfect focus where it is needed - in the eye - ... light beam and infinity focus, ensures that whate...
The Beta 200S combines Heine's patented aspherical optics (U.S. Pat. 4.963.014) and a single-step Rekoss disk with a range of 36 to +38 dpt. to provide perfectly-focused images even in cases of high
The Heine Beta 200S is the first hand-held direct ophthalmoscope with a combination of patented aspherical optics (U.S. Pat. 4.963.014) and a range of corrective lenses from 36 to +38 dpt. in single
...ptics. Includes XHL halogen bulb. The separation o...e aspherical optical system avoids corneal and iri...ws you to view the whole of the illuminated sectio...nal ophthalmoscopes often let you see only part of...
Medicine Products: